LabCompass

Publications

63

Citations

822

Est. group size

Recurring co-author estimate

Active years

19

Publishing since 2007

Research summary
AI-generated

Xin Yi studies molecular mechanisms in cancer and cell biology, with particular attention to how small regulatory molecules called microRNAs and cell-signaling pathways influence tumor growth, drug resistance, and cell differentiation. The work spans cancer diagnostics (such as blood-based tests for early detection), natural compounds and plant-derived molecules with therapeutic effects, and the biology of stem cells and cell proliferation. Studies use a range of models including human cancer cell lines and zebrafish.

Cancer molecular biology and drug resistanceMicroRNA regulation of cellsNatural compounds and plant-derived therapeuticsStem cell differentiation and bone biologyNanoparticle-based cancer targeting and detection

Publication activity peaked around 2019–2021, dropped sharply thereafter (including a gap in 2023), and has continued at a lower level of a few papers per year through 2025.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 2.0/year recently
2017: 4 publications172018: 3 publications182019: 9 publications192020: 16 publications16202021: 8 publications212022: 3 publications22232024: 3 publications242025: 4 publications2526
Recent publications
Publishes in
  • bioRxiv (Cold Spring Harbor Laboratory)×5
  • Scientific Reports×3
  • Research Square×3
  • International Journal of Biological Macromolecules×2
  • JBMR Plus×2

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile